The cultured fibroblast model

  • J. P. Blass
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 44)


Cultured skin fibroblasts have been successfully used to elucidate the molecular and biochemical bases of a large number of inborn errors of metabolism which cause neurological disease. The fibroblast model is now being extended to studies of genetic diseases of the nervous system with later clinical onset, including Alzheimer’s Disease (AD). Persistence in the cultured cells of an abnormality found in AD brain provides evidence that the abnormality in brain is not simply a reflection of anatomic or chemical damage in the clinically affected tissue. Biochemical and cell biological studies of AD fibroblasts are succeeding in implicating molecules which warrant further study at the molecular genetic level. In neurological diseases with an important genetic component, including AD, studies of fibroblasts can be a useful adjunct to studies of brain.


Phytanic Acid Inborn Error Cell Biological Study Cumulative Population Doubling Level Important Genetic Component 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ali G, Cai X, Sheu KFR, Szabo P, Cooper AJL, Blass JP (1993) a-ketoglutarate dehydrogenase: a candidate gene for Alzheimer’s disease? J Neurochem 61: 5177Google Scholar
  2. Black RS, Bouvier MM, Sheu KFR, Darzynkiewicz Z, Blass JP (1992) Presence of typical neuronal markers in serially cultured cells from adult human brain. J Neurol Sci 107: 223–232CrossRefGoogle Scholar
  3. Blass JP (1993a) Metabolic alterations common to neural and non-neural cells in Alzheimer’s disease. Hippocampus 3: 45–54PubMedGoogle Scholar
  4. Blass JP (1993b) Pathophysiology of the Alzheimer’s syndrome. Neurology 43 [Suppl]4: S25–S38Google Scholar
  5. Blass JP, DeGiorgio LA (1992) Tissue culture and studies of human brain disease. J Neurol Sci 113: 1–3PubMedCrossRefGoogle Scholar
  6. Black RS, DeGiorgio LA, Sheu KFR, Darzynkiewicz Z, Duffy JT, Blass JP (1993) Expression of neuronal proteins in a cell line derived from adult rat brain. J Neurochem 62: 2132–2140CrossRefGoogle Scholar
  7. Blass JP, Gibson GE (1991) The role of oxidative abnormalities in the pathophysiology of Alzheimer’s disease. Rev Neurol (Paris) 147: 513–525Google Scholar
  8. Blass JP, Markesbery WR, Ko L, DeGiorgio L, Sheu KFR, Darzynkiewicz Z (1993) Presence of neuronal proteins in serially cultured cells from autopsy human brain. J Neurol Sci 121: 132–138CrossRefGoogle Scholar
  9. Blass JP, Sheu KFR, Ko L, Bancher CL, Wisniewski HM, Bouvier M, Duffy JT, Baker AC (1992) Presence of low amounts of “neuronal” antigens in cultured human skin fibroblasts. J Neurol Sci 107: 223–232PubMedCrossRefGoogle Scholar
  10. DeKeyser J, Ebinger G, Vauquelin G (1990) Dl-dopamine receptor abnormality in frontal cortex points to a functional alteration of cortical cell membranes in Alzheimer’s disease. Arch Neurol 47: 761–763PubMedCrossRefGoogle Scholar
  11. Gibson GE, Sheu KFR, Blass JP, Baker A, Carlson KC, Harding B, Blass JP (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer’s disease. Arch Neurol 45: 836–840PubMedCrossRefGoogle Scholar
  12. Herndon JH Jr, Steinberg D, Uhlendorf BW, Fales HM (1969) Refsum’s disease: characterization of the enzyme defect in cell culture. J Clin Invest 48: 1017–1024PubMedCrossRefGoogle Scholar
  13. Huang H-M, Gibson GE (1993) Altered (3-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. J Biol Chem 268: 14616–14621PubMedGoogle Scholar
  14. Jung E-H, Sheu KFR, Blass JP (1993) An enzymatic and immunochemical analysis of transketolase in fibroblasts from Wernicke-Korsakoff syndrome. J Neurol Sci 114: 123–127PubMedCrossRefGoogle Scholar
  15. Koike K, Urata Y, Goto S (1992) Cloning and nucleotide sequence of the cDNA encoding human 2-oxoglutarate dehydrogenase (lipoamide). Proc Natl Acad Sci USA 89: 1963–1967PubMedCrossRefGoogle Scholar
  16. Mastrogiacomo F, Bergeron C, Kish SJ (1993) Brain a-ketoglutarate dehydrogenase activity in Alzheimer’s disease. J Neurochem 61: 2007–2014PubMedCrossRefGoogle Scholar
  17. Paoletti F, Mocali A, Marchi S, Sorbi S, Piacentinni S (1990) Occurrence of transketolase abnormality in extracts of foreskin fibroblasts from patients with Alzheimer’s disease. Biochem Biophys Res Commun 172: 396–401PubMedCrossRefGoogle Scholar
  18. Pericek-Vance M, Foncin JF, Montesi F, et al (1992) Genetic evidence for a novel familial Alzheimer’s locus on chromosome 14. Nature Genet 2: 330–334CrossRefGoogle Scholar
  19. Pons G, Raefshy-Estrin C, Carothers DJ (1988) Cloning and DNA sequence in the dihydrolipoamide dehydrogenase component of human a-ketoacid dehydrogenase complexes. Proc Natl Acad Sci USA 85: 1422–1426PubMedCrossRefGoogle Scholar
  20. Peterson C, Goldman JE (1986) Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci USA 83: 2758–2762PubMedCrossRefGoogle Scholar
  21. Sheu KFR, Clarke DD, Kim YT, Blass JP, Harding BJ, DeCicco J (1988) Studies of the transketolase abnormality in Alzheimer’s disease. Arch Neurol 45: 841–845PubMedCrossRefGoogle Scholar
  22. Sheu KFR, Cooper AJL, Lindsay JG, Blass JP (1993) Abnormality of the a- ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer’s disease. Ann Neurol 35: 312–318CrossRefGoogle Scholar
  23. Sheu KFR, Kim YY, Blass JP, Weksler M (1985) An immunochemical study on the deficit of pyruvate dehydrogenase in Alzheimer’s disease brain. Ann Neurol 17: 444–449PubMedCrossRefGoogle Scholar
  24. Sims NBR, Finegan JM, Blass JP (1987) Altered metabolic properties of cultured skin fibroblasts in Alzheimer’s disease. Ann Neurol 21: 451–457PubMedCrossRefGoogle Scholar
  25. Smith CJ, Perry EK, Perry RH, Fairbairn AF, Birdsall NJM (1987) Guanine nucleotide modulation of muscarinic cholinergic receptor binding in post-mortem human brain — a preliminary study in Alzheimer’s disease. Neurosci Lett 82: 227–232PubMedCrossRefGoogle Scholar
  26. Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) (1983) The metabolic basis of inherited disease, 5th edn. McGraw Hill, New York Steinberg D (1983) Phytanic acid storage disease (Refsum’s disease). In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th edn. McGraw Hill, New York, pp 731–747Google Scholar
  27. Tofel-Grehl B, Blass JP, Gibson GE (1992) Heterogeneity in CPDL to phase-out among fibroblasts from different Alzheimer families. Mol Biol Cell 35: 1898Google Scholar
  28. Westlind-Danielsson A, et al. (1988) VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimyer’s disease/senile dementia of the Alzheimer type. Neurobiol Aging 9: 153 - 162PubMedCrossRefGoogle Scholar
  29. Yates CM, Butterworth J, Tennant MC, Gordon A (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem 55: 1624–1630PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • J. P. Blass
    • 1
  1. 1.Altschul Laboratory for Dementia Research, Burke Medical Research InstituteCornell University Medical CollegeWhite PlainsUSA

Personalised recommendations